Relationship Between Delay Discounting and Clinical Diabetes Outcomes: A Systematic Review
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Higher delay discounting, the tendency to prefer smaller immediate rewards over larger future ones, is linked to poorer diabetes management and outcomes. This highlights the need for targeted interventions to improve population health.
Area Of Science
- Behavioral economics
- Clinical psychology
- Endocrinology
Background
- Delay discounting, the devaluation of future rewards, is a key concept in behavioral economics.
- Understanding its role in chronic disease management is crucial for public health.
Purpose Of The Study
- To review evidence linking delay discounting to clinical diabetes outcomes.
- To identify current measurement tools for delay discounting.
- To suggest future research directions.
Main Methods
- Systematic literature search across major databases (OVID Medline, PsycINFO, PubMed, Science Direct, Scopus).
- Inclusion of articles up to March 2024 using keywords for delay discounting and diabetes.
- Analysis of outcomes including HbA1c, BMI, self-care, and quality of life.
Main Results
- 14 of 15 reviewed studies found a significant association between higher delay discounting and worse diabetes outcomes.
- This relationship was observed for HbA1c, self-care behaviors, BMI, stress, and quality of life.
- Findings were consistent across self-reported measures and behavioral tasks of delay discounting.
Conclusions
- Strong evidence supports the link between delay discounting and adverse diabetes outcomes and self-care.
- Further multidisciplinary research is needed to validate delay discounting as a mechanism and develop targeted interventions.
- Intervention refinement is essential for improving population health in diabetes management.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...